Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
July 6th, 2014
18.8K views
The use of cytobrush sampling to collect lymphocytes and monocytes from the endocervix is a minimally invasive technique that provides samples for analysis of female genital tract immunity. In this protocol, we describe the collection of cytobrush samples and immune cell isolation for flow cytometry assays.
Overview
This protocol describes a minimally invasive technique for collecting lymphocytes and monocytes from the endocervix using cytobrush sampling. The isolated cells can be analyzed for immune function in the female genital tract.
Key Study Components
Area of Science
- Immunology
- Gynecology
- Cell Biology
Background
- Cytobrush sampling is a non-invasive method.
- It allows for the collection of immune cells from the female genital tract.
- Flow cytometry can be used to analyze these cells.
- Understanding immune cell function is crucial for female reproductive health.
Purpose of Study
- To isolate cervical mononuclear cells from endocervical samples.
- To facilitate analysis of immune cell phenotype and function.
- To provide a protocol for gynecologists and trained physicians.
Methods Used
- Collection of cervical lavage samples using PBS.
- Sampling the cervical os with a cervical scraper.
- Using a cyto brush to collect cells from the endocervical os.
- Flow cytometry for subsequent analysis of isolated cells.
Main Results
- Successful isolation of cervical mononuclear cells.
- Feasibility of using cytobrush sampling in clinical settings.
- Potential for analyzing immune responses in the female genital tract.
- Demonstrated method for non-invasive sample collection.
Conclusions
- Cytobrush sampling is effective for immune cell isolation.
- Provides a valuable tool for studying female genital tract immunity.
- Can enhance understanding of reproductive health and disease.
Frequently Asked Questions
What is cytobrush sampling?
Cytobrush sampling is a minimally invasive technique used to collect lymphocytes and monocytes from the endocervix.
Who can perform this procedure?
The procedure must be performed by a gynecologist or a trained physician.
What assays can be performed with the isolated cells?
The isolated cells can be used in various assays, including flow cytometry.
Is this method invasive?
No, cytobrush sampling is a non-invasive procedure.
What is the purpose of cervical lavage?
Cervical lavage is performed to wash the endocervix and collect samples for analysis.
What can be analyzed using flow cytometry?
Flow cytometry can be used to determine the phenotype and function of immune cells.
Executive Industry Relevance
Understanding mucosal immunity in the female genital tract is critical for evaluating HIV transmission risk and vaccine efficacy. This protocol enables minimally invasive collection and phenotypic analysis of cervical mononuclear cells, supporting target validation in infectious disease research. The approach provides quantitative immune profiling that informs mechanistic de-risking of mucosal vaccine candidates.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying lymphocyte and monocyte phenotypes in the endocervical microenvironment.
- Operational Value: Provides a reproducible method for isolating viable immune cells from minimally invasive cytobrush samples.
- Predictive Value: Supports assessment of immune activation markers like CD69 and HLA-DR, which correlate with HIV susceptibility.
Screening & Assay Development
- Scientific Value: Generates standardized single-cell suspensions suitable for flow cytometric analysis of surface and intracellular markers.
- Operational Value: Includes defined steps for cell dissociation, filtration, and washing to ensure sample consistency across donors.
- Assay Readiness: Enables coupling with cervical-vaginal lavage for simultaneous soluble mediator analysis (e.g., cytokines, chemokines).
Translational & Preclinical Research
- Translational Continuity: Links ex vivo phenotypic data from human endocervical samples to mechanisms of mucosal immune regulation.
- Biomarker Alignment: Permits quantification of HIV co-receptors (e.g., CCR5) and checkpoint markers (e.g., PD-1) relevant to transmission and pathogenesis.
- Risk-Adjusted Decision-Making: Facilitates evaluation of immune environments that may influence vaccine take or breakthrough infection.
Pipeline & Workflow Integration
The method fits within early discovery workflows by providing primary human tissue-derived immune cells for hypothesis testing prior to model-based screening.
- Discovery Biology: Enables direct phenotypic profiling of CD4+ and CD8+ T-cell subsets in the female genital tract, a key site for HIV transmission.
- Screening: Produces standardized cell preparations that support reproducible antibody staining and flow cytometric readouts.
- Analytics: Delivers quantitative frequency and expression data for immune phenotypes, enabling inter-sample comparison and gating strategy development.
- Translational Research: Connects cellular phenotype data with soluble mediator profiles from cervical-vaginal lavage to define local immune milieu.
- Enterprise Reuse: Establishes a scalable, minimally invasive sampling technique applicable across infectious disease and vaccine development programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by providing human-relevant mucosal immune data.
- Operational Value: Standardizes sample processing steps (e.g., vortex dissociation, filtration, centrifugation) to minimize variability.
- Strategic Value: Reduces reliance on invasive biopsies, improving sample acquisition feasibility in clinical studies.
- Portfolio Impact: Informs go/no-go decisions by characterizing mucosal immune activation states that may predict vaccine efficacy or HIV susceptibility.
Implementation Considerations
- Requires training in cytobrush technique and sterile sample handling to avoid blood contamination.
- Depends on access to flow cytometry and antibody panels validated for cervical mononuclear cells.
- Necessitates cold chain maintenance (ice transport, 4°C processing) to preserve cell viability.
- Involves exclusion criteria for blood-contaminated samples to ensure data integrity.
- Requires optimization of antibody titration and viability gating due to higher doublet rates and variable lymphocyte yields compared to PBMCs.
Biopharma FAQs
Why is vortex dissociation critical for cytobrush sample processing?
Vortexing the cytobrush sample in PBS for 45 seconds dissociates immune cells from the brush bristles, enabling efficient recovery of cervical mononuclear cells for downstream flow cytometry analysis.
How does filtration through a 100-micron nylon filter support sample preparation?
Filtration removes mucus, debris, and cytobrush fragments while allowing lymphocytes, monocytes, and epithelial cells to pass through, yielding a purified single-cell suspension for staining.
What is the purpose of centrifuging samples at 1500 rpm for 10 minutes without brake?
Centrifugation at 1500 rpm for 10 minutes with the brake off pellets cells gently, preventing disruption of the cell pellet and preserving viability for flow cytometry.
Why is a blocking solution containing mouse IgG used before antibody staining?
The blocking solution minimizes non-specific antibody binding to cervical mononuclear cells, improving staining specificity and reducing background noise in flow cytometry data.
How is viability assessed and why is it important in cervical mononuclear cell analysis?
Viability is assessed using a dye incubated for 30 minutes at 4°C in the dark; excluding dead cells is critical because they can non-specifically bind antibodies and confound phenotypic analysis of lymphocyte populations.
